Promoter polymorphisms which modulate BACE1 expression are associated with sporadic Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

• Publication date

  2009-05-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ajmg.b.30968PMID 19441127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• A Comparative Study of β-Amyloid Peptides Aβ1-42 and Aβ25-35 Toxicity in Organotypic Hippocampal Slice Cultures

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• BACE1 Polymorphisms Do Not Influence Platelet Membrane β-secretase Activity or Genetic Susceptibility for Alzheimer’s Disease in the Northern Irish Population

  2008cited by this paper
• Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease.

  2008cited by this paper
• Inhibitory effects of short-term administration of dl-α-lipoic acid on oxidative vulnerability induced by Aβ amyloid fibrils (25–35) in mice

  2008cited by this paper
• Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

  2008cited by this paper
• BACE1 structure and function in health and Alzheimer's disease.

  2008cited by this paper
• Association of BACE1 Gene Polymorphism with Alzheimer’s Disease in Asian Populations: Meta-Analysis Including Korean Samples

  2008cited by this paper
• Genetic association of BACE1 gene polymorphism C786G with late-onset Alzheimer’s disease in Chinese

  2007cited by this paper
• BACE1 gene promoter is differentially regulated

  2007influential reference
• Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.

  2007cited by this paper
• Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

  2007cited by this paper
• Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice*

  2007cited by this paper
• Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.

  2007cited by this paper
• IFN‐γ‐induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes

  2007cited by this paper
• Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation*

  2007cited by this paper
• Association of genetic variants of ABCA1 with Alzheimer's disease risk

  2007cited by this paper
• Variations in the APP gene promoter region and risk of Alzheimer disease

  2007cited by this paper
• Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

  2007cited by this paper
• Transcriptional Regulation of PEN-2, a Key Component of the γ-Secretase Complex, by CREB

  2006cited by this paper
• Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.

  2006cited by this paper
• Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

  2006cited by this paper
• Taking down the unindicted co-conspirators of amyloid beta-peptide-mediated neuronal death: shared gene regulation of BACE1 and APP genes interacting with CREB, Fe65 and YY1 transcription factors.

  2006influential reference
• Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease.

  2005cited by this paper
• Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients

  2005cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005influential reference
• Gene structure and organization of the human β‐secretase (BACE) promoter

  2004cited by this paper
• BACE1: the beta-secretase enzyme in Alzheimer's disease.

  2004influential reference
• Amyloid (cid:1) peptide load is correlated with increased (cid:1) -secretase activity in sporadic Alzheimer’s disease patients

  2004cited by this paper
• Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1

  2004cited by this paper
• Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.

  2004cited by this paper
• The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans

  2004cited by this paper
• BACE1 Suppression by RNA Interference in Primary Cortical Neurons*

  2004cited by this paper
• Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.

  2004influential reference
• HIF1 and oxygen sensing in the brain

  2004cited by this paper
• Gene structure and organization of the human beta-secretase (BACE) promoter.

  2004cited by this paper
• Polymorphism in the BACE gene influences the risk for Alzheimer's disease

  2003cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003cited by this paper
• Results of a high-resolution genome screen of 437 Alzheimer's disease families.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• The −48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain

  2001cited by this paper
• Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

  2000cited by this paper
• Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide

  1999cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Overview of BACE1 structure and effect of genetic polymorphisms and protein isoforms on enzyme activity

  2025cites this paper
• Relationship between the polymorphism in exon 5 of BACE1 gene and Alzheimer’s disease

  2017cites this paper
• Meta-analysis of BACE1 gene rs638405 polymorphism and the risk of Alzheimer's disease in Caucasion and Asian population.

  2016cites this paper
• Original Article The association of three BACE1 gene polymorphisms (exon5 C/G, intron 5 T/G and 3'UTR T/A) with sporadic Alzheimer's disease susceptibility: a meta-analysis

  2015cites this paper
• The association of three BACE1 gene polymorphisms (exon5 C/G, intron 5 T/G and 3'UTR T/A) with sporadic Alzheimer's disease susceptibility: a meta-analysis.

  2015influential citation
• Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease.

  2015cites this paper
• Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model.

  2012cites this paper
• New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

  2012cites this paper
• Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

  2012cites this paper
• Association of BACE1 Gene Polymorphism with Cerebellar Volume but Not Cognitive Function in Normal Individuals

  2012cites this paper
• The −980C /G polymorphism in APH‐1A promoter confers risk of Alzheimer’s disease

  2011cites this paper
• Alzheimer's Disease: Definition, Molecular and Genetic Factors

  2011cites this paper
• Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism

  2011cites this paper
• The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif.

  2011cites this paper